FDA inspection
PREMIER NORTH AMERICA: FDA inspection ending Jan 3, 2024
FDA inspection 1226816 · No Action Indicated (NAI) · Fort Lauderdale, FL
Key facts
| Inspection ID | 1226816 |
|---|---|
| Firm | PREMIER NORTH AMERICA |
| FEI number | 3014412531 |
| Address | 1321 Nw 65th Pl Ste A |
| City | Fort Lauderdale |
| State | FL |
| ZIP | 33309 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Jan 3, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data